Haloperidol and Methyldopa: Interaction Details
AI-assisted, pharmacist-reviewed · Source data updated Aug 8, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Haloperidol
No brand names on recordMethyldopa
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
What happens
CNS toxicity (dementia) or reversible parkinsonism
Interaction Deep Dive
Cases of marked increases of psychotic behavior or newly developed bizarre behavior have developed within one week after the addition of haloperidol to an established methyldopa regimen. The abnormal behavior dramatically improved within days upon discontinuation of either agent. The few cases reported do not establish a cause-effect relationship, but the combination should be used with caution and the patient observed closely for several days12.
Why it happens (mechanism)
Increased dopamine inhibition
Literature reports
3 reports — tap to read
a) Two male patients experienced adverse mental effects resulting from combined methyldopa and haloperidol therapy 1. The first case was a 48-year-old male patient with hypertension treated with 1 gram per day of methyldopa for three years. Following initiation of 8 milligrams per day of haloperidol for anxiety, the patient developed symptoms of psychomotor retardation, memory impairment, ideas of reference with accompanying inappropriate suspiciousness, and inability to do mathematical calculations. Discontinuing the haloperidol resulted in resolution of these symptoms within 48 hours. The second case was a 43-year-old male patient with hypertension treated with 1.5 grams per day of methyldopa for 18 months who developed symptoms of disorientation, inability to recognize own handwriting, inability to concentrate and marked slowing of both motor and muscle performance within three days after starting 6 milligrams per day of haloperidol for anxiety. Following discontinuation of the haloperidol, the symptoms disappeared completely within 72 hours.
b) A patient became irritable, aggressive, assaultive and unmanageable several days after receiving combination therapy with haloperidol and methyldopa 2. Improvement in symptoms occurred as soon as methyldopa was discontinued.
c) The potentiation of haloperidol by methyldopa was studied in patients with schizophrenia 3. Ten patients were maintained on haloperidol 10 milligrams and methyldopa 500 milligrams daily from day 2 until the end of the 4-week trial. Among the ten patients, 20 incidences of extrapyramidal side effects were reported, which exceeds the expected incidence of extrapyramidal side effects of 25% following therapeutic doses of haloperidol 4. Antiparkinsonian medication was needed in eight out of 10 patients to control these drug-induced extrapyramidal effects. Somnolence was noted in eight patients and considered severe in two.
Common questions
Can I take Haloperidol and Methyldopa together?
CNS toxicity (dementia) or reversible parkinsonism Always confirm with your pharmacist or prescriber before making any change.
How serious is the Haloperidol and Methyldopa interaction?
It is rated moderate. Can be significant — usually manageable with monitoring.
How quickly could this interaction happen?
The documented onset is "delayed". Effects tend to build up gradually over days to weeks.
How strong is the evidence for this interaction?
The evidence is graded "established". Well documented — supported by controlled studies or strong clinical data.
Questions for your pharmacist
- Does my dose of Haloperidol or Methyldopa need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there anything you'd monitor while I'm on both?
References (4)
- Thornton WE: Dementia induced by methyldopa with haloperidol. N Engl J Med 1976; 294:1222. DOI
- Nadel I & Wallach M: Drug interaction between haloperidol and methyldopa (letter). Br J Psychiatry 1979; 135:484. PubMed
- Chouinard G, Pinard G, Serrano M, et al: Potentiation of haloperidol by alpha-methyldopa in the treatment of schizophrenic patients. Curr Ther Res 1973; 15:473-483.
- Anon: Boston Collaborative Surveillance Program: Drug-induced extrapyramidal symptoms. A cooperative study. JAMA 1973; 224:889-891. DOI
Keep reading about Haloperidol
Keep reading about Methyldopa
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist